🇺🇸 FDA

Drug profile · INN

prasugrel hydrochloride

PRASUGREL

approved
US status
approved
Patents linked
3
News articles
0

Quick answer

prasugrel hydrochloride (PRASUGREL) is an FDA-listed pharmaceutical active ingredient. Associated with Amneal Pharma Europe Ltd. Route of administration: oral. Current US regulatory status: approved.

Key facts

INN prasugrel hydrochloride
Brand PRASUGREL
Route ORAL
Formulation TABLET
Originator Amneal Pharma Europe Ltd

Related patents

Search patents →

  1. US 9012641

    Crystalline forms of Prasugrel salts

    Expires Mon Apr 16 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  2. US 8937053

    Process for the preparation of prasugrel and several novel crystalline forms of prasugrel hydrochloride

    Expires Mon Jan 15 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  3. US 8802854

    Crystalline forms of Prasugrel salts

    Expires Mon Aug 07 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

Frequently asked questions

What is prasugrel hydrochloride?

prasugrel hydrochloride (PRASUGREL) is an FDA-listed pharmaceutical active ingredient. Associated with Amneal Pharma Europe Ltd. Route of administration: oral. Current US regulatory status: approved.

What is the brand name for prasugrel hydrochloride?

PRASUGREL is a marketed brand name for prasugrel hydrochloride. Check FDA Drugs@FDA for the current US label holder and prescribing information.

What is the US approval status of prasugrel hydrochloride?

prasugrel hydrochloride has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.